PlumX Metrics
Embed PlumX Metrics

Perspectives for the development of human papillomavirus vaccines and immunotherapy

Expert Review of Vaccines, ISSN: 1476-0584, Vol: 9, Issue: 1, Page: 35-44
2010
  • 12
    Citations
  • 0
    Usage
  • 30
    Captures
  • 0
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

Review Description

Human papillomavirus (HPV) is the most common sexually transmitted infection and is responsible for 90-99% of cervical cancer (CxCa) cases. Although effective screening programs have reduced the incidence of CxCa in developed countries, they are often not well organized. Prophylactic vaccination against HPV seems to be a good strategy for the prevention of CxCa. However, because millions of women are already infected with HPV, therapeutic HPV vaccines need to be developed further to treat these women. This review discusses the actual perspectives on both HPV vaccines and immunotherapy worldwide. In addition, some of the perspectives in France are also briefly discussed. © 2010 Expert Reviews Ltd.

Bibliographic Details

Bermúdez-Humarán, Luis G; Langella, Philippe

Informa UK Limited

Immunology and Microbiology; Biochemistry, Genetics and Molecular Biology; Pharmacology, Toxicology and Pharmaceutics

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know